5 ML cisatracurium 2 MG/ML Injection — RxCUI 1730194
RxNorm drug concept · Semantic clinical drug
RxCUI 1730194
Semantic clinical drug · SCD
● Current RxNorm concept 35 FDA products
39 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1730194
Official name5 ML cisatracurium 2 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascisatracurium (as cisatracurium besylate) 10 MG per 5 ML Injection; cisatracurium besylate 10 MG in 5 ML Injection
FDA products mapped35
Package NDCs mapped39
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Cisatracurium: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It relaxes your muscles during anesthesia so a breathing tube can be placed and surgery can be done safely. It is also used in adults on a breathing machine in the ICU. You will al...
- It is given only through an IV by trained clinicians, either as an injection or a continuous drip. They adjust the amount to how you respond and check your muscles with a nerve sti...
- Side effects are uncommon. They can include a slow heart rate, low blood pressure, flushing, airway tightening or a rash. Your care team watches for these and can treat them quickl...
- Yes. Mention any allergic reactions to anesthesia medicines, muscle diseases like myasthenia gravis, and kidney or liver problems. Also tell them about medicines such as phenytoin,...
🕸️ Concept Web — How 5 ML cisatracurium 2 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
5 ML cisatracurium 2 MG/ML Injection
RxCUI 1730194 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Cisatracurium
319864IN
-
Cisatracurium
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Nimbex
136560BN
-
Nimbex
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Cisatracurium Injection
1730193SCDF -
Cisatracurium Injectable Product
1152128SCDG -
Cisatracurium Injection [Nimbex]
1730195SBDF -
Nimbex Injectable Product
1183912SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Cisatracurium Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Cisatracurium 2 MG/ML
330567SCDC -
5 ML cisatracurium 2 MG/ML Injection [Nimbex]
1730196SBD -
Cisatracurium 2 MG/ML [Nimbex]
571178SBDC
-
Cisatracurium 2 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Cisatracurium 2 MG/ML
SCDC · 330567 -
Cisatracurium Injection
SCDF · 1730193 -
Cisatracurium Injectable Product
SCDG · 1152128
Brand-Name Concepts
-
5 ML cisatracurium 2 MG/ML Injection [Nimbex]
SBD · 1730196 -
Cisatracurium 2 MG/ML [Nimbex]
SBDC · 571178 -
Cisatracurium Injection [Nimbex]
SBDF · 1730195 -
Nimbex Injectable Product
SBDG · 1183912 -
Nimbex
BN · 136560
📦 FDA Products & Package NDCs
35 products · 39 package NDCs
39 package NDCs map to RxCUI 1730194 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-9160-10 | 10 VIAL in 1 CARTON (0143-9160-10) / 20 mL in 1 VIAL (0143-... | Cisatracurium Besylate | Hikma Pharmaceuticals USA Inc. | 2025-03-17 |
| 00143-9396-01 | 1 VIAL in 1 CARTON (0143-9396-01) / 5 mL in 1 VIAL | Cisatracurium Besylate | Hikma Pharmaceuticals USA Inc. | 2023-05-31 |
| 00409-1098-02 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1098-02) / 5 mL in 1... | Cisatracurium Besylate | Hospira, Inc. | 2020-03-17 |
| 00409-1103-01 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1103-01) / 20 mL in... | Cisatracurium Besylate | Hospira, Inc. | 2019-12-02 |
| 00409-1208-01 | 10 VIAL, MULTI-DOSE in 1 CARTON (0409-1208-01) / 10 mL in 1... | Cisatracurium Besylate | Hospira, Inc. | 2020-03-24 |
| 00781-3150-95 | 10 BOX in 1 CARTON (0781-3150-95) / 1 VIAL in 1 BOX (0781-3... | cisatracurium besylate | Sandoz Inc | 2012-07-16 |
| 00781-3153-95 | 10 BOX in 1 CARTON (0781-3153-95) / 1 VIAL in 1 BOX (0781-3... | cisatracurium besylate | Sandoz Inc | 2012-07-16 |
| 31722-0312-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (31722-312-10) / 20 mL in... | Cisatracurium Besylate | Camber Pharmaceuticals Inc. | 2026-05-04 |
| 31722-0313-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (31722-313-10) / 5 mL in 1... | Cisatracurium Besylate | Camber Pharmaceuticals Inc. | 2026-05-04 |
| 31722-0314-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (31722-314-10) / 10 mL in 1... | Cisatracurium Besylate | Camber Pharmaceuticals Inc. | 2026-05-04 |
| 55150-0284-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-284-10) / 5 mL in 1... | Cisatracurium Besylate | Eugia US LLC | 2020-10-27 |
| 55150-0286-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (55150-286-10) / 10 mL in 1... | Cisatracurium Besylate | Eugia US LLC | 2020-05-08 |
| 63323-0416-05 | 10 VIAL in 1 CARTON (63323-416-05) / 5 mL in 1 VIAL (63323-... | Cisatracurium | Fresenius Kabi USA, LLC | 2015-02-26 |
| 63323-0417-10 | 10 VIAL in 1 CARTON (63323-417-10) / 10 mL in 1 VIAL (63323... | Cisatracurium | Fresenius Kabi USA, LLC | 2015-02-26 |
| 63323-0418-20 | 10 VIAL in 1 CARTON (63323-418-20) / 20 mL in 1 VIAL (63323... | Cisatracurium | Fresenius Kabi USA, LLC | 2015-02-26 |
| 65145-0135-01 | 1 VIAL, SINGLE-USE in 1 CARTON (65145-135-01) / 5 mL in 1 V... | Cisatracurium besylate | Caplin Steriles Limited | 2025-01-17 |
| 65145-0135-10 | 10 VIAL, SINGLE-USE in 1 CARTON (65145-135-10) / 5 mL in 1... | Cisatracurium besylate | Caplin Steriles Limited | 2025-01-17 |
| 65145-0136-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (65145-136-01) / 10 mL in 1... | Cisatracurium besylate | Caplin Steriles Limited | 2025-01-17 |
| 65145-0136-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (65145-136-10) / 10 mL in 1... | Cisatracurium besylate | Caplin Steriles Limited | 2025-01-17 |
| 65145-0137-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (65145-137-01) / 20 mL in 1... | Cisatracurium besylate | Caplin Steriles Limited | 2025-01-17 |
| 68083-0486-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-486-01) / 5 mL in 1... | Cisatracurium besylate | Gland Pharma Limited | 2025-03-19 |
| 68083-0487-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-487-01) / 20 mL in 1... | Cisatracurium besylate | Gland Pharma Limited | 2025-03-19 |
| 68083-0488-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (68083-488-01) / 10 mL in 1... | Cisatracurium besylate | Gland Pharma Limited | 2025-03-19 |
| 70069-0141-01 | 1 VIAL in 1 CARTON (70069-141-01) / 5 mL in 1 VIAL | Cisatracurium Besylate | Somerset Therapeutics, LLC | 2019-02-04 |
| 70069-0141-10 | 10 VIAL in 1 CARTON (70069-141-10) / 5 mL in 1 VIAL | Cisatracurium Besylate | Somerset Therapeutics, LLC | 2019-02-04 |
| 70069-0151-01 | 1 VIAL in 1 CARTON (70069-151-01) / 20 mL in 1 VIAL | Cisatracurium Besylate | Somerset Therapeutics, LLC | 2019-02-04 |
| 70069-0151-10 | 10 VIAL in 1 CARTON (70069-151-10) / 20 mL in 1 VIAL | Cisatracurium Besylate | Somerset Therapeutics, LLC | 2019-02-04 |
| 70436-0112-82 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70436-112-82) / 5 mL in 1... | Cisatracurium besylate | Slate Run Pharmaceuticals, LLC | 2021-09-02 |
| 70436-0114-82 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70436-114-82) / 20 mL in... | Cisatracurium besylate | Slate Run Pharmaceuticals, LLC | 2021-09-02 |
| 70710-1532-06 | 10 VIAL in 1 CARTON (70710-1532-6) / 5 mL in 1 VIAL (70710-... | cisatracurium besylate | Zydus Pharmaceuticals USA Inc. | 2020-02-12 |
| 70710-1534-06 | 10 VIAL in 1 CARTON (70710-1534-6) / 20 mL in 1 VIAL (70710... | cisatracurium besylate | Zydus Pharmaceuticals USA Inc. | 2020-02-12 |
| 71288-0712-06 | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-712-06) / 5 mL in 1... | Cisatracurium Besylate | Meitheal Pharmaceuticals Inc. | 2019-10-31 |
| 71288-0712-96 | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-712-96) / 5 mL in 1... | Cisatracurium Besylate | Meitheal Pharmaceuticals Inc. | 2019-10-31 |
| 71288-0713-21 | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-713-21) / 20 mL in... | Cisatracurium Besylate | Meitheal Pharmaceuticals Inc. | 2019-10-31 |
| 71288-0713-96 | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-713-96) / 20 mL in... | Cisatracurium Besylate | Meitheal Pharmaceuticals Inc. | 2019-10-31 |
| 71288-0714-11 | 10 VIAL, MULTI-DOSE in 1 CARTON (71288-714-11) / 10 mL in 1... | Cisatracurium Besylate | Meitheal Pharmaceuticals Inc. | 2019-10-31 |
| 71288-0714-96 | 10 VIAL, MULTI-DOSE in 1 CARTON (71288-714-96) / 10 mL in 1... | Cisatracurium Besylate | Meitheal Pharmaceuticals Inc. | 2019-10-31 |
| 72785-0008-06 | 10 VIAL in 1 CARTON (72785-0008-6) / 5 mL in 1 VIAL (72785-... | cisatracurium besylate | Zydus Lifesciences Limited | 2020-02-12 |
| 72785-0009-06 | 10 VIAL in 1 CARTON (72785-0009-6) / 20 mL in 1 VIAL (72785... | cisatracurium besylate | Zydus Lifesciences Limited | 2020-02-12 |
Observed labelers:
Meitheal Pharmaceuticals Inc. (6) ·
Caplin Steriles Limited (5) ·
Somerset Therapeutics, LLC (4) ·
Camber Pharmaceuticals Inc. (3) ·
Fresenius Kabi USA, LLC (3) ·
Gland Pharma Limited (3)
· +7 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.